Nanoparticles--a historical perspective

Author(s): Kreuter J

Abstract

The historical development of nanoparticles starting with Paul Ehrlich and then first attempts by Ursula Scheffel and colleagues and the extensive work by the group of Professor Peter Speiser at the ETH Zürich in the late 1960s and early 1970s are described from a personal point of view. Special attention is given to the years between 1970 and the early 1980s. Further developments resulting from this work are also followed, and focus is placed on especially interesting improvements such as nanoparticles for the delivery of drugs across the blood-brain barrier (BBB) and PEGylated nanoparticles with a prolonged blood circulation time.

Similar Articles

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Author(s): Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al.

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features

Author(s): Nelson D, Nelson J, Davis D, Chang C, Griffins T, et al.

Radium-223 in the treatment of osteoblastic metastases: a critical clinical review

Author(s): Humm JL, Sartor O, Parker C, Bruland OS, Macklis R

Alpha emitter radium-223 and survival in metastatic prostate cancer

Author(s): Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, et al.

Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis

Author(s): Bhattacharyya S, Bhattacharya R, Curley S, McNiven MA, Mukherjee P

Effect of nanoparticle surface charge at the plasma membrane and beyond

Author(s): Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, et al.

Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles

Author(s): Arvizo RR, Miranda OR, Moyano DF, Walden CA, Giri K, et al.

Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign

Author(s): Bhattacharyya S, Singh RD, Pagano R, Robertson JD, Bhattacharya R, et al.

Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors

Author(s): Kennel SJ, Chappell LL, Dadachova K, Brechbiel MW, Lankford TK, et al.

LnPO4 nanoparticles doped with Ac-225 and sequestered daughters for targeted alpha therapy

Author(s): McLaughlin MF, Robertson D, Pevsner PH, Wall JS, Mirzadeh S, et al.

LaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter Radionuclides

Author(s): Woodward J, Kennel SJ, Stuckey A, Osborne D, Wall J, et al.

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy

Author(s): McLaughlin MF, Woodward J, Boll RA, Wall JS, Rondinone AJ, et al.

Bioelectric effects of intense ultrashort pulses

Author(s): Joshi RP, Schoenbach KH

Nanosecond pulsed electric field thresholds for nanopore formation in neural cells

Author(s): Roth CC, Tolstykh GP, Payne JA, Kuipers MA, Thompson GL